Faster Cancer-Fighting cells: new hope for kids with tough leukemia
NCT ID NCT05480449
Summary
This study is testing a new, faster way to make a personalized cancer treatment called CAR-T cell therapy for children and young adults with a hard-to-treat blood cancer called B-cell acute lymphoblastic leukemia (B-ALL). The goal is to see if using an automated machine to make the treatment is safe and effective, and if it can get the therapy to patients more quickly than the old, slower method. The trial will enroll up to 89 participants aged 0 to 29 years who have not responded well to other treatments.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for B LINEAGE LYMPHOBLASTIC LYMPHOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Children's Hospital of Philadelphia
RECRUITINGPhiladelphia, Pennsylvania, 19104, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.